Document is current

Any future updates will be listed below

24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk

Crossref DOI link: https://doi.org/10.1007/s12325-017-0568-x

Published Online: 2017-06-19

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark